BORTEZOMIB for injection, for subcutaneous or intravenous use

Manufacturer
Zydus Lifesciences Limited | Zydus Hospira Oncology Private Limited
Effective date
2022-05-05
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:41:21

Label at a glance#

ProductBORTEZOMIB
Active ingredientBORTEZOMIB
Label structure1 sections

Label contents#

Full prescribing information#

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 70771-1708-1

Bortezomib for Injection

3.5 mg/vial

For Intravenous or Subcutaneous Use

One Single-dose Vial

Rx only

vial label
vial label

NDC 70771-1708-1

Bortezomib for Injection – Carton label

3.5 mg/vial

For Intravenous or Subcutaneous Use

Reconstitution Information

SUBCUTANEOUS INJECTION ONLY

0.9% NaCl

Add

1.4 mL

0.9% Sodium Chloride

To make

2.5 mg/mL

final concentration

INTRAVENOUS INJECTION ONLY

0.9% NaCl

Add

3.5 mL

0.9% Sodium Chloride

To make

1 mg/mL

final concentration

One Single-dose Vial

Rx only

carton label
carton label

Reconstitution Information – Inside Flap (All cartons)

SUBCUTANEOUS INJECTION ONLY

0.9% NaCl

Add

1.4 mL

0.9% Sodium Chloride

To make

2.5 mg/mL

final concentration

INTRAVENOUS INJECTION ONLY

0.9% NaCl

Add

3.5 mL

0.9% Sodium Chloride

To make

1 mg/mL

final concentration

Inside Flap image
Inside Flap image

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
402243bortezomib 3.5 MG InjectionPSN1
402243bortezomib 3.5 MG InjectionSCD1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
BORTEZOMIB Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeDataBar Omni(01)00370771170814GTIN-14: 00370771170814
GTIN-12: 370771170814
UPC-A: 370771170814
EAN-13: 0370771170814
GTIN storage (14 digits): 00370771170814
a7ff2205-566b-4fb5-8f33-bf73377ee093-01.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b069d653-565d-b331-cf82-116aa266aee9Product name420260317
987023d7-918d-4465-be3c-f3f8f784679bProduct name120250318
2cff6375-aa9a-4194-a1db-33f6ed6564f1Product name120230322
f8ade071-6be1-4cb3-a390-e8ba41353f9bProduct name120230322
c3c5823c-3bc3-46c2-bc6a-295b30affa78Product name120230113
6429b384-c989-4e27-bc69-c5e1c7dc2e31Product name120200304
71c1111b-030c-4ada-94cb-bf623cfad8ecProduct name120180108

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70771-1708-1BORTEZOMIB3.5 mL in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, LYOPHILIZED,3.51
70771-1708-1BORTEZOMIB1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70771-1708BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ZYDUS LIFESCIENCES LIMITED]1Current NDC, Legacy NDC, 2 package rows20220505_582c7c0d-fa25-4586-8157-a1e2653d72d9.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70771-170870771-1708-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
BORTEZOMIB69G8BD63PPACTIB
MANNITOL3OWL53L36AIACT

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A210204-001BORTEZOMIBBORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A210204-001AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02d4dbc9d85df4…
2026-10-15 13:18:302026-09A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02c2088c7a36db…
2026-09-14 22:38:342026-08A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-0284e616aacf4f…
2026-08-18 06:07:402026-07A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-0231067a03dcf5…
2025-08-23 18:47 UTC2025-08A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-026a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-0203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-022680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-025bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-0279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-021e350fbaab3a…
2024-05-31 18:47 UTC2024-05A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-028072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-025c6f7cd8ea54…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-026a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-021c564ffb4f44…
2023-12-20 04:57 UTC2023-12A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-029b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-023f0d92c62455…
2023-05-13 08:27 UTC2023-05A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02053a50430f4f…
2023-01-26 05:58 UTC2023-01A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-023bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-023a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A210204-001BORTEZOMIB3.5MG/VIALINJECTABLE / INTRAVENOUS, SUBCUTANEOUSAP2022-05-02a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A210204-001AP1d4dbc9d85df4…
2026-10-15 13:18:302026-09A210204-001AP1c2088c7a36db…
2026-09-14 22:38:342026-08A210204-001AP184e616aacf4f…
2026-08-18 06:07:402026-07A210204-001AP1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A210204-001AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210204-001AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08A210204-001AP16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210204-001AP1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210204-001AP1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210204-001AP103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210204-001AP12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210204-001AP15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210204-001AP1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A210204-001AP1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210204-001AP179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210204-001AP1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210204-001AP11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A210204-001AP18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A210204-001AP15c6f7cd8ea54…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A210204-001AP16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A210204-001AP11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A210204-001AP1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A210204-001AP1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A210204-001AP19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A210204-001AP1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A210204-001AP13f0d92c62455…
2023-05-13 08:27 UTC2023-05A210204-001AP1053a50430f4f…
2023-01-26 05:58 UTC2023-01A210204-001AP13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A210204-001AP13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A210204-001AP1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A210204-001AP1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A210204-001AP1cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A210204-001AP1a50c72e98297…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BORTEZOMIBBORTEZOMIBZydus Lifesciences Limited582c7c0d-fa25-4586-8157-a1e2653d72d92022-05-05Exact identifier
ndc (package): 70771-1708-1
ndc (product): 70771-1708
ndc11 (package): 70771170801
spl id: a7ff2205-566b-4fb5-8f33-bf73377ee093
spl set id: 582c7c0d-fa25-4586-8157-a1e2653d72d9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.